
Chinese General Practice ›› 2023, Vol. 26 ›› Issue (18): 2293-2300.DOI: 10.12114/j.issn.1007-9572.2022.0603
Special Issue: 心血管最新文章合辑
• Evidence-based Medicine • Previous Articles Next Articles
Received:2022-06-10
Revised:2022-09-10
Published:2023-06-20
Online:2022-10-27
Contact:
JIANG Yunlan
通讯作者:
蒋运兰
作者简介:基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0603
| 步骤 | 检索式 |
|---|---|
| #1 | "Deglutition Disorders" [Mesh] |
| #2 | dysphagia[Title/Abstract] OR deglutition dysfunction[Title/Abstract] OR deglutition impairment[Title/Abstract] OR deglutition decline[Title/Abstract] OR deglutition disorder*[Title/Abstract] OR swallowing disorder*[Title/Abstract] OR impaired swallowing[Title/Abstract] |
| #3 | #1 or #2 |
| #4 | "Cardiac Surgical Procedures" [Mesh] |
| #5 | Cardiac surgery[Title/Abstract] OR heart surgery[Title/Abstract] OR coronary artery bypass grafting[Title/Abstract] OR CABG[Title/Abstract] OR valv*surgery[Title/Abstract] OR valv* replacement[Title/Abstract] |
| #6 | #4 or #5 |
| #7 | "Prevalence" [Mesh]OR "Epidemiology" [Mesh]OR "Incidence" [Mesh] |
| #8 | Prevalence*[Title/Abstract] OR epidemi*[Title/Abstract] OR incidence*[Title/Abstract] OR frequenc*[Title/Abstract] ORoccurrence*[Title/Abstract] |
| #9 | #7 or #8 |
| #10 | #3 and #6 and #9 |
Table 1 Strategy for searching studies on incidence of dysphagia after cardiac surgery in PubMed database
| 步骤 | 检索式 |
|---|---|
| #1 | "Deglutition Disorders" [Mesh] |
| #2 | dysphagia[Title/Abstract] OR deglutition dysfunction[Title/Abstract] OR deglutition impairment[Title/Abstract] OR deglutition decline[Title/Abstract] OR deglutition disorder*[Title/Abstract] OR swallowing disorder*[Title/Abstract] OR impaired swallowing[Title/Abstract] |
| #3 | #1 or #2 |
| #4 | "Cardiac Surgical Procedures" [Mesh] |
| #5 | Cardiac surgery[Title/Abstract] OR heart surgery[Title/Abstract] OR coronary artery bypass grafting[Title/Abstract] OR CABG[Title/Abstract] OR valv*surgery[Title/Abstract] OR valv* replacement[Title/Abstract] |
| #6 | #4 or #5 |
| #7 | "Prevalence" [Mesh]OR "Epidemiology" [Mesh]OR "Incidence" [Mesh] |
| #8 | Prevalence*[Title/Abstract] OR epidemi*[Title/Abstract] OR incidence*[Title/Abstract] OR frequenc*[Title/Abstract] ORoccurrence*[Title/Abstract] |
| #9 | #7 or #8 |
| #10 | #3 and #6 and #9 |
| 第一作者 | 发表时间(年) | 国家 | 样本量(例,发病人数/未发病人数) | 年龄(岁,病例组/对照组) | 评估工具 | 手术方式 | 发病率(%) | 研究设计 | 危险因素 | 质量评价(分) |
|---|---|---|---|---|---|---|---|---|---|---|
| NAKAMURA[ | 2021 | 日本 | 192(15/177) | — | FILS | TAVI/SAVR | 7.81 | 队列研究 | ⑦ | 7 |
| BARKER[ | 2009 | 加拿大 | 254(130/124) | 64.5±12.6a | SPBA | CABG/VR等 | 51.18 | 病例对照研究 | ③⑨⑩ | 8 |
| ROUSOU[ | 2000 | 美国 | 838(23/815) | — | 吞钡造影检查 | CABG/VR等 | 2.74 | 队列研究 | ③⑨⑪ | 7 |
| ZHOU[ | 2019 | 中国 | 395(103/292) | 61.7±12.8a | GUSS | CABG等 | 26.08 | 横断面研究 | ③⑧⑫⑱ | 6 |
| MUKDAD[ | 2019 | 美国 | 197(10/187) | 82.7±11.5a | 床旁评估+FEES | TAVR | 5.08 | 队列研究 | ③ | 6 |
| 程红萍[ | 2018 | 中国 | 158(60/98) | 57.15±10.33a | WST | CABG/VR | 37.97 | 病例对照研究 | ①②③④⑤ | 5 |
| 丁志威[ | 2018 | 中国 | 386(28/358) | 60.2±8.6 /55.7±9.5 | WST | CABG/VR/ CABG+VR/CHD等 | 7.25 | 病例对照研究 | ④⑤⑥ | 6 |
| 叶兰[ | 2018 | 中国 | 106(30/76) | 64.5±6.0a | WST | 急诊PCI | 28.30 | 病例对照研究 | ③④⑤ | 6 |
| 胡可鉴[ | 2016 | 中国 | 452(32/420) | 62±8/58±10 | WST | CABG/VR/ CABG+VR/CHD等 | 7.08 | 病例对照研究 | ③④⑤⑥ | 7 |
| 周萌[ | 2016 | 中国 | 578(47/531) | 55.59±12.47a | WST | CABG/VR/CABG+VR/CHD等 | 8.13 | 横断面研究 | ③④⑤⑥ | 8 |
| DALY[ | 2016 | 新西兰 | 190(33/157) | 61.3±15.0a | SPBA+FEES/VFSS | CABG/VR/HT等 | 17.37 | 病例对照研究 | ⑧⑨⑬ | 8 |
| GRIMM[ | 2015 | 美国 | 1 314(115/1 199) | 52~74a | SPBA+ VFSS | CABG/VR/VAD/HT等 | 8.75 | 病例对照研究 | ②③⑦⑧⑮⑯⑲ | 7 |
| SKORETZ[ | 2014 | 加拿大 | 909(51/858) | 65.9±12.0a | SPBA | CABG/VR | 5.61 | 病例对照研究 | ①③⑩ | 8 |
| FERRARIS[ | 2001 | 美国 | 1 042(31/1 011) | 71.9±8.3 /62.8±11.8 | MBS | CABG等 | 2.98 | 横断面研究 | ⑭⑰⑳ | 7 |
| HOGUE[ | 1995 | 美国 | 869(34/835) | 71.0±2.0 /63.0±0.4 | 吞钡造影检查 | CABG/VR/CABG+VR/AS等 | 3.91 | 横断面研究 | ①③⑪ | 8 |
Table 2 Basic information and methodological quality of included studies
| 第一作者 | 发表时间(年) | 国家 | 样本量(例,发病人数/未发病人数) | 年龄(岁,病例组/对照组) | 评估工具 | 手术方式 | 发病率(%) | 研究设计 | 危险因素 | 质量评价(分) |
|---|---|---|---|---|---|---|---|---|---|---|
| NAKAMURA[ | 2021 | 日本 | 192(15/177) | — | FILS | TAVI/SAVR | 7.81 | 队列研究 | ⑦ | 7 |
| BARKER[ | 2009 | 加拿大 | 254(130/124) | 64.5±12.6a | SPBA | CABG/VR等 | 51.18 | 病例对照研究 | ③⑨⑩ | 8 |
| ROUSOU[ | 2000 | 美国 | 838(23/815) | — | 吞钡造影检查 | CABG/VR等 | 2.74 | 队列研究 | ③⑨⑪ | 7 |
| ZHOU[ | 2019 | 中国 | 395(103/292) | 61.7±12.8a | GUSS | CABG等 | 26.08 | 横断面研究 | ③⑧⑫⑱ | 6 |
| MUKDAD[ | 2019 | 美国 | 197(10/187) | 82.7±11.5a | 床旁评估+FEES | TAVR | 5.08 | 队列研究 | ③ | 6 |
| 程红萍[ | 2018 | 中国 | 158(60/98) | 57.15±10.33a | WST | CABG/VR | 37.97 | 病例对照研究 | ①②③④⑤ | 5 |
| 丁志威[ | 2018 | 中国 | 386(28/358) | 60.2±8.6 /55.7±9.5 | WST | CABG/VR/ CABG+VR/CHD等 | 7.25 | 病例对照研究 | ④⑤⑥ | 6 |
| 叶兰[ | 2018 | 中国 | 106(30/76) | 64.5±6.0a | WST | 急诊PCI | 28.30 | 病例对照研究 | ③④⑤ | 6 |
| 胡可鉴[ | 2016 | 中国 | 452(32/420) | 62±8/58±10 | WST | CABG/VR/ CABG+VR/CHD等 | 7.08 | 病例对照研究 | ③④⑤⑥ | 7 |
| 周萌[ | 2016 | 中国 | 578(47/531) | 55.59±12.47a | WST | CABG/VR/CABG+VR/CHD等 | 8.13 | 横断面研究 | ③④⑤⑥ | 8 |
| DALY[ | 2016 | 新西兰 | 190(33/157) | 61.3±15.0a | SPBA+FEES/VFSS | CABG/VR/HT等 | 17.37 | 病例对照研究 | ⑧⑨⑬ | 8 |
| GRIMM[ | 2015 | 美国 | 1 314(115/1 199) | 52~74a | SPBA+ VFSS | CABG/VR/VAD/HT等 | 8.75 | 病例对照研究 | ②③⑦⑧⑮⑯⑲ | 7 |
| SKORETZ[ | 2014 | 加拿大 | 909(51/858) | 65.9±12.0a | SPBA | CABG/VR | 5.61 | 病例对照研究 | ①③⑩ | 8 |
| FERRARIS[ | 2001 | 美国 | 1 042(31/1 011) | 71.9±8.3 /62.8±11.8 | MBS | CABG等 | 2.98 | 横断面研究 | ⑭⑰⑳ | 7 |
| HOGUE[ | 1995 | 美国 | 869(34/835) | 71.0±2.0 /63.0±0.4 | 吞钡造影检查 | CABG/VR/CABG+VR/AS等 | 3.91 | 横断面研究 | ①③⑪ | 8 |
| 亚组 | 纳入研究数量(篇) | 异质性检验结果 | 效应模型 | Meta分析结果合并率(95%CI) | |
|---|---|---|---|---|---|
| I2值(%) | P值 | ||||
| 地区 | |||||
| 亚洲 | 7[ | 95.6 | <0.001 | 随机 | 16.6(10.4,22.8) |
| 北美洲 | 7[ | 97.8 | <0.001 | 随机 | 10.0(6.1,13.8) |
| 大洋洲 | 1[ | — | — | — | 17.4(12.3,23.5) |
| 性别 | |||||
| 男 | 10[ | 96.9 | <0.001 | 随机 | 16.9(11.8,21.9) |
| 女 | 10[ | 93.1 | <0.001 | 随机 | 16.4(11.1,21.8) |
| 年龄(岁) | |||||
| <70 | 2[ | 97.1 | <0.001 | 随机 | 10.9(8.6,13.5) |
| ≥70 | 2[ | 93.7 | <0.001 | 随机 | 28.4(19.7,37.9) |
| NYHA心功能分级(级) | |||||
| Ⅰ~Ⅱ | 9[ | 92.2 | <0.001 | 随机 | 11.8(7.4,16.3) |
| Ⅲ~Ⅳ | 7[ | 96.4 | <0.001 | 随机 | 21.0(11.0,30.9) |
| 围术期气管插管时间(h) | |||||
| <12 | 3[ | 0 | 0.43 | 固定 | 1.0(0.3,1.8) |
| 12~24 | 2[ | 0 | 0.39 | 固定 | 6.4(4.4,8.3) |
| 25~48 | 2[ | 0 | 0.97 | 固定 | 16.8(9.5,24.1) |
| >48 | 4[ | 97.3 | <0.001 | 随机 | 55.0(28.0,82.0) |
| 慢性肾脏疾病 | |||||
| 有 | 5[ | 71.8 | 0.014 | 随机 | 13.1(3.8,22.4) |
| 无 | 5[ | 91.3 | <0.001 | 随机 | 7.1(4.0,10.1) |
| 慢性肺部疾病 | |||||
| 有 | 8[ | 81.3 | <0.001 | 随机 | 15.5(7.8,23.2) |
| 无 | 8[ | 97.4 | <0.001 | 随机 | 12.7(8.3,17.2) |
| 脑血管意外史 | |||||
| 有 | 8[ | 93.2 | <0.001 | 随机 | 19.2(10.1,28.4) |
| 无 | 8[ | 94.3 | <0.001 | 随机 | 9.5(6.5,12.6) |
| 术前心房颤动史 | |||||
| 有 | 3[ | 59.2 | 0.086 | 随机 | 22.7(13.4,32.0) |
| 无 | 3[ | 96.9 | <0.001 | 随机 | 11.7(3.9,19.4) |
| 术前心力衰竭史 | |||||
| 有 | 5[ | 96.5 | <0.001 | 随机 | 24.3(9.9,38.6) |
| 无 | 5[ | 97.1 | <0.001 | 随机 | 10.4(5.8,15.0) |
| 术中TEE | |||||
| 使用 | 7[ | 76.6 | <0.001 | 随机 | 10.1(6.8,13.4) |
| 未使用 | 7[ | 93.9 | <0.001 | 随机 | 7.4(4.1,10.7) |
| 围术期脑卒中 | |||||
| 有 | 4[ | 86.9 | <0.001 | 随机 | 56.1(27.4,84.8) |
| 无 | 4[ | 98.3 | <0.001 | 随机 | 18.6(9.0,28.1) |
| 围术期败血症 | |||||
| 有 | 2[ | 32.8 | 0.22 | 固定 | 17.3(8.6,26.0) |
| 无 | 2[ | 92.5 | <0.001 | 随机 | 5.9(4.5,7.3) |
Table 3 Subgroup analyses of the incidence of dysphagia after cardiac surgery
| 亚组 | 纳入研究数量(篇) | 异质性检验结果 | 效应模型 | Meta分析结果合并率(95%CI) | |
|---|---|---|---|---|---|
| I2值(%) | P值 | ||||
| 地区 | |||||
| 亚洲 | 7[ | 95.6 | <0.001 | 随机 | 16.6(10.4,22.8) |
| 北美洲 | 7[ | 97.8 | <0.001 | 随机 | 10.0(6.1,13.8) |
| 大洋洲 | 1[ | — | — | — | 17.4(12.3,23.5) |
| 性别 | |||||
| 男 | 10[ | 96.9 | <0.001 | 随机 | 16.9(11.8,21.9) |
| 女 | 10[ | 93.1 | <0.001 | 随机 | 16.4(11.1,21.8) |
| 年龄(岁) | |||||
| <70 | 2[ | 97.1 | <0.001 | 随机 | 10.9(8.6,13.5) |
| ≥70 | 2[ | 93.7 | <0.001 | 随机 | 28.4(19.7,37.9) |
| NYHA心功能分级(级) | |||||
| Ⅰ~Ⅱ | 9[ | 92.2 | <0.001 | 随机 | 11.8(7.4,16.3) |
| Ⅲ~Ⅳ | 7[ | 96.4 | <0.001 | 随机 | 21.0(11.0,30.9) |
| 围术期气管插管时间(h) | |||||
| <12 | 3[ | 0 | 0.43 | 固定 | 1.0(0.3,1.8) |
| 12~24 | 2[ | 0 | 0.39 | 固定 | 6.4(4.4,8.3) |
| 25~48 | 2[ | 0 | 0.97 | 固定 | 16.8(9.5,24.1) |
| >48 | 4[ | 97.3 | <0.001 | 随机 | 55.0(28.0,82.0) |
| 慢性肾脏疾病 | |||||
| 有 | 5[ | 71.8 | 0.014 | 随机 | 13.1(3.8,22.4) |
| 无 | 5[ | 91.3 | <0.001 | 随机 | 7.1(4.0,10.1) |
| 慢性肺部疾病 | |||||
| 有 | 8[ | 81.3 | <0.001 | 随机 | 15.5(7.8,23.2) |
| 无 | 8[ | 97.4 | <0.001 | 随机 | 12.7(8.3,17.2) |
| 脑血管意外史 | |||||
| 有 | 8[ | 93.2 | <0.001 | 随机 | 19.2(10.1,28.4) |
| 无 | 8[ | 94.3 | <0.001 | 随机 | 9.5(6.5,12.6) |
| 术前心房颤动史 | |||||
| 有 | 3[ | 59.2 | 0.086 | 随机 | 22.7(13.4,32.0) |
| 无 | 3[ | 96.9 | <0.001 | 随机 | 11.7(3.9,19.4) |
| 术前心力衰竭史 | |||||
| 有 | 5[ | 96.5 | <0.001 | 随机 | 24.3(9.9,38.6) |
| 无 | 5[ | 97.1 | <0.001 | 随机 | 10.4(5.8,15.0) |
| 术中TEE | |||||
| 使用 | 7[ | 76.6 | <0.001 | 随机 | 10.1(6.8,13.4) |
| 未使用 | 7[ | 93.9 | <0.001 | 随机 | 7.4(4.1,10.7) |
| 围术期脑卒中 | |||||
| 有 | 4[ | 86.9 | <0.001 | 随机 | 56.1(27.4,84.8) |
| 无 | 4[ | 98.3 | <0.001 | 随机 | 18.6(9.0,28.1) |
| 围术期败血症 | |||||
| 有 | 2[ | 32.8 | 0.22 | 固定 | 17.3(8.6,26.0) |
| 无 | 2[ | 92.5 | <0.001 | 随机 | 5.9(4.5,7.3) |
| [1] |
窦祖林. 吞咽障碍评估与治疗[M]. 2版. 北京:人民卫生出版社,2017.
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
曾宪涛,刘慧,陈曦,等. Meta分析系列之四:观察性研究的质量评价工具[J]. 中国循证心血管医学杂志,2012,4(4):297-299.
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
程红萍,杨红梅. 心脏手术后患者吞咽困难危险因素调查[J]. 中华现代护理杂志,2018,24(24):2896-2899. DOI:10.3760/cma.j.issn.1674-2907.2018.24.010.
|
| [16] |
丁志威,谢周良,权晓强,等. 心脏外科术后发生获得性吞咽障碍的影响因素[J]. 临床医学,2018,38(7):39-41. DOI:10.19528/j.issn.1003-3548.2018.07.15.
|
| [17] |
叶兰,张丽淼,李腾. 气管插管呼吸机支持下急诊经皮冠状动脉介入治疗后吞咽障碍的发生率及影响因素分析[J]. 安徽医学,2018,39(11):1373-1376. DOI:10.3969/j.issn.1000-0399.2018.11.021.
|
| [18] |
胡可鉴,周萌,梁涛,等. 成人心脏外科术后患者发生获得性吞咽障碍的相关因素研究[J]. 中国循环杂志,2016,31(8):793-796. DOI:10.3969/j.issn.1000-3614.2016.08.016.
|
| [19] |
周萌. 心脏术后患者获得性吞咽障碍发生现状及危险因素分析[D]. 北京:北京协和医学院,2016.
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
万娜,王艳玲,张春艳,等. ICU患者获得性吞咽障碍发生现状及危险因素分析[J]. 中国护理管理,2018,18(11):1467-1471. DOI:10.3969/j.issn.1672-1756.2018.11.007.
|
| [28] |
|
| [29] |
余金甜,陈俊杉,张爱琴. 心脏术后患者发生获得性吞咽障碍危险因素的Meta分析[J]. 中华护理杂志,2020,55(3):451-456. DOI:10.3761/j.issn.0254-1769.2020.03.027.
|
| [30] |
任慧玲,黄素芳. 气管插管病人拔管后获得性吞咽困难的研究进展[J]. 护理研究,2015,29(8):904-907.
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
刘妮,郑则广. COPD患者口咽部吞咽障碍研究进展[J]. 国际呼吸杂志,2016,36(21):1652-1656.
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [1] | CHAI Zhihao, ZHANG Weisen, LUO Jiaoling, ZHU Feng, ZHU Tong, JIN Yali, PAN Jing, LU Yingjun, JIANG Chaoqiang. The Mediation Effect of Socioeconomic Status in Childhood Parental Literacy and Cognitive Function in Middle-aged and Older People: Based on Guangzhou Biobank Cohort Study [J]. Chinese General Practice, 2026, 29(21): 2959-2966. |
| [2] | HAN Congcong, QIU Xinyu, SHAN Chunfang, SONG Ning, CHEN Qingjie, MULADILI· Abudureheman, LI Xiaomei, YANG Yining, ZHAO Qian. Impact of Metabolic Obesity Phenotype on Long-term Prognosis after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome [J]. Chinese General Practice, 2026, 29(21): 2950-2958. |
| [3] | LIU Shuai, YUAN Shizhao, LIU Yan, JIA Shuoxian, ZHAO Yan, WANG Ziyi, ZHOU Chunhua, YU Jing. Evaluation of the Efficacy, Safetyand Economy of Different Amphotericin B Formulationsin Invasive Fungal Disease: a Retrospective Cohort Study [J]. Chinese General Practice, 2026, 29(21): 2967-2974. |
| [4] | WU Yixuan, XIAO Liangman, LIU Xin, YAN Ziqi, WANG Yuting, LIN Shumin, ZHUANG Lixing. Analysis of the Disease Burden of Parkinson's Disease in China and Globally from 1990 to 2021 and Prediction of Future Trends [J]. Chinese General Practice, 2026, 29(20): 2895-2902. |
| [5] | REYILAI· Maimaiti, ZHOU Yiran, WU Yun, LIU Zhencheng, LU Yaoqin, WU Haiyan. Association between Novel Obesity Indicators and Cardiovascular Disease Risk in Hypertensive Patients [J]. Chinese General Practice, 2026, 29(20): 2836-2845. |
| [6] | LI Yutong, ZHAO Danting, JIANG Feng, WANG Yanna, LIU Yizong, LIANG Wenjuan, LU Jiahai. Systematic Review and Meta-analysis of the Efficacy and Safety of mRNA and Recombinant Protein Subunit Vaccines Against Respiratory Syncytial Virus [J]. Chinese General Practice, 2026, 29(19): 2744-2752. |
| [7] | ZHANG Wenbo, WANG Junlong, ZHANG Yuping, JIANG Shuai, WANG Huaqi. The Risk of Pre-COPD Populations Progressing to COPD under Different Criteria: a Meta-analysis [J]. Chinese General Practice, 2026, 29(19): 2735-2743. |
| [8] | QIU Xinyu, ZHAO Qian, CHEN Yufei, JIAMULE· Maimaitiyiming, HAN Congcong, AIKEDAN· Aierken, LI Xiaomei, YANG Yining. Weight Status and Metabolic Characteristics on the Longitudinal Trajectory of Systolic Blood Pressure: a Cohort Study [J]. Chinese General Practice, 2026, 29(15): 2006-2013. |
| [9] | TIAN Anni, YANG Jing, SUN Jing, WANG Shichun. Effect of Robot-assisted Training on the Recovery of Hand Motor Function in Patients with Different Stages of Stroke: a Meta-analysis [J]. Chinese General Practice, 2026, 29(14): 1911-1920. |
| [10] | ZHAN Li, HENG Zhaoyang, HE Liangyu, ZHAO Jie, CHEN Jie, XING Jinshan. Efficacy and Safety of CAR-T Therapy Targeting the B Cell Maturation Antigen on Relapsed/Refractory Multiple Myeloma in Chinese People: a Meta-analysis [J]. Chinese General Practice, 2026, 29(14): 1921-1930. |
| [11] | LIU Xiang, CHEN Hong, CUI Rui, GUO Zhichao, LI Panpan, CAO Zilong, JI Yiqing, YU Wenya. Consistencies and Differences in Early Childhood Development Characteristics in Megacities: a Retrospective Cohort Study [J]. Chinese General Practice, 2026, 29(11): 1411-1421. |
| [12] | WANG Fei, HAN Weiyu, SUN Tao. Moxibustion Combined with Three-step Therapy in the Treatment of Cancer Pain: a Network Meta-analysis [J]. Chinese General Practice, 2026, 29(09): 1203-1211. |
| [13] | LI Qiuchun, SU Ping, PANG Jinhong, CHEN Qiaoqiao, ZHAO Yingying, HE Ruiyan, WANG Yue, CHEN Xueyu, QIAO Junpeng, CHI Weiwei. Association of Triglyceride Glucose Index with Cardiovascular Disease in Cardiovascular-Kidney-Metabolic Syndrome Stage 0-3 Population: a Prospective Cohort Study [J]. Chinese General Practice, 2026, 29(09): 1129-1136. |
| [14] | PEI Zhiyi, ZHANG Xiaoxin, LIN Jiayi, ZHANG Xiangyi, KANG Xiaofeng. Systematic Review of the Quality and Application of Patient Decision Aids in Cardiovascular Disease Based on IPDAS 4.0 Criteria [J]. Chinese General Practice, 2026, 29(07): 945-952. |
| [15] | ZHAO Qianqian, ZHANG Mei, LI Yanying, ZHANG Yanhong, YAN Wenhua, PAN Hui, BAN Bo. Clinical Characteristics of Growth Hormone Deficiency and Analysis of the Efficacy of Recombinant Human Growth Hormone: a Ten-year Longitudinal Cohort Study [J]. Chinese General Practice, 2026, 29(06): 733-740. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||